COR

Cencora, Inc.

HealthcareMedical DistributionNASDAQ

$269.36

+$3.98 (1.48%)today

Conviction

0/ 10

Fair Value$407.92

Upside+51.44%

Signal0

Market Cap$62.4B

52W Range$269.37–$377.54

Next EarningsMay 6

Price History

FAIR VALUE ANALYSISMonte Carlo · 5,000 runs · 99% valid

Fair Value$5286.13

Current Price$312.45

Upside / Down+1591.8%

P(Undervalued)100.0%

P(20%+ Up)100.0%

P(15%+ Down)0.0%

Fair Value Distribution — percentile bands

100.0% of simulations place fair value above current price

WHAT IS PRICED IN

FCF-Based Reverse DCF

0.8%/yr

±3.1% · FCF growth to justify current price

Premium Content

Upgrade to premium for full distribution data, sensitivity analysis, and segment breakdowns.

Quick Take

Cencora, Inc.

Trailing P/E38.6x

Forward P/E16.3x

P/S0.2x

EPS (TTM)$8.31

Analyst Target$407.92

Analyst Upside51.4%

No Eagle analysis yet. Request a full review including conviction score, bull/bear cases, and thesis.

Bull Case

No analysis yet

Bear Case

No analysis yet

Research Feed

sec_10qMar 2

Conviction: unchanged

Cencora Q1 FY2026: RCA Integration + GLP-1 Momentum

Cencora delivered strong Q1 results with 5.5% revenue growth to .9B and impressive 20.1% gross profit expansion. The January 2025 RCA acquisition (B) is meaningfully accretive—gross margin expanded 46...